CR, a 57 y/o male, presents to your hospital and is being treated for severe pneumonia in the ICU. You order the patient for broad spectrum coverage including vancomycin, a glycopeptide, and cefepime, a fourth generation cephalosporin. What organisms would these agents be uniquely targeting given the severity of his pneumonia?